Investigator #218 — Littleton, Colorado

Investigator #218 is a clinical research site located in Littleton, Colorado, United States 80120.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigator #218 has participated in 1 clinical trials.

Therapeutic areas: Kerato Conjunctivitis Sicca.

Sponsors: Kala Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Littleton

Browse all research sites in Colorado · View every site in Littleton

• Littleton Adventist Hospital
• Obstetrix Medical Group - Colorado at Littleton Adventist Hospital Perinatal Care Center
• University of Colorado Health Sciences Center
• Centura Littleton Adventist Hospital
• SCL Health - Saint Joseph Hospital Cancer Center
• Rocky Mountain Cancer Centers-Littleton
• AdventHealth Littleton
• South Denver Cardiology Associates PC
• South Denver Cardiology Associates
• Rocky Mountain Cancer Centers
• Research Site
• GSK Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator #218?

Investigator #218 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator #218 conducted?

Investigator #218 has 1 clinical trials on record. Their work covers Kerato Conjunctivitis Sicca.

Is Investigator #218 accredited by Crixeo Clinical Trials?

Investigator #218 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator #218?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.